Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -71.72% is 704% below its 3-year average of -8.92%, near the low end of its 3-year range (-71.72%–12.71%).
As of the fiscal period ended Monday, June 30, 2025. 143.08% below its 12-month average of -29.50%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2025 (2025-12-31): 1.33%.
RETURN ON ASSETS (ROA)
-71.72%
RETURN ON ASSETS (ROA) AVG TTM
-29.50%
RETURN ON ASSETS (ROA) AVG 3Y
-8.92%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-143.08%
CURRENT VS 3Y AVG
-704.04%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-24.95%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
-187.45%
vs the sector median at left
Basel Medical Group Ltd Ordinary Shares
Market Cap
$4.96M
Return on Assets (ROA)
-71.72%
TTM Avg
-29.50%
3Y Avg
-8.92%
5Y Avg
N/A
Market Cap
$4.99M
Return on Assets (ROA)
-30.94%
TTM Avg
-24.01%
3Y Avg
-19.50%
5Y Avg
-23.56%
Market Cap
$4.85M
Return on Assets (ROA)
-108.91%
TTM Avg
-143.36%
3Y Avg
-200.57%
5Y Avg
-146.87%
Market Cap
$4.79M
Return on Assets (ROA)
-28.02%
TTM Avg
-155.25%
3Y Avg
-160.56%
5Y Avg
-117.99%
Market Cap
$5.21M
Return on Assets (ROA)
-98.17%
TTM Avg
-154.79%
3Y Avg
-120.06%
5Y Avg
-94.26%
Market Cap
$5.36M
Return on Assets (ROA)
-106.49%
TTM Avg
-259.99%
3Y Avg
-586.63%
5Y Avg
-434.16%
Market Cap
$4.46M
Return on Assets (ROA)
-157.28%
TTM Avg
-221.91%
3Y Avg
-169.98%
5Y Avg
-213.74%
Market Cap
$4.42M
Return on Assets (ROA)
-173.86%
TTM Avg
-97.65%
3Y Avg
-65.17%
5Y Avg
-52.25%
Market Cap
$4.41M
Return on Assets (ROA)
-194.09%
TTM Avg
-543.36%
3Y Avg
-310.28%
5Y Avg
-256.27%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Basel Medical Group Ltd Ordinary Shares (BMGL) | $4.96M | -71.72% | -29.50% | -8.92% | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | -30.94% | -24.01% | -19.50% | -23.56% |
| CalciMedica, Inc. (CALC)vs › | $4.85M | -108.91% | -143.36% | -200.57% | -146.87% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | -28.02% | -155.25% | -160.56% | -117.99% |
| Imunon, Inc. (IMNN)vs › | $5.21M | -98.17% | -154.79% | -120.06% | -94.26% |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | -106.49% | -259.99% | -586.63% | -434.16% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | -157.28% | -221.91% | -169.98% | -213.74% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | -173.86% | -97.65% | -65.17% | -52.25% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | -194.09% | -543.36% | -310.28% | -256.27% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -94.96% | -122.01% | -81.62% | -58.26% |
ROA
-71.7%
ROE
-248.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-06-30 | -71.72% |
| 2024-06-30 | 12.71% |
| 2023-06-30 | 11.59% |
| 2022-06-30 | 11.74% |
